In Brief: CollaGenex Periostat
CollaGenex Periostat: Innovative Customer Solutions will assist with U.S. launch of Periostat upon FDA marketing clearance. An NDA for Periostat for treatment of periodontal disease was filed in August. ICS, a sales and marketing firm specializing in the dental market, is run by former Procter & Gamble oral care division executives...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth